HBsAg and HBeAg in the prediction of a clinical response to peginterferon α-2b therapy in Chinese HBeAg-positive patients.
Yang S, Xing H, Wang Y, Hou J, Luo D, Xie Q, Ning Q, Ren H, Ding H, Sheng J, Wei L, Chen S, Fan X, Huang W, Pan C, Gao Z, Zhang J, Zhou B, Chen G, Wan M, Tang H, Wang G, Yang Y, Xu D, Dong P, Wang Q, Wang J, Bognar FA, Xu D, Cheng J.
Yang S, et al. Among authors: yang y.
Virol J. 2016 Oct 28;13(1):180. doi: 10.1186/s12985-016-0640-1.
Virol J. 2016.
PMID: 27793166
Free PMC article.
Clinical Trial.